Pipex Pharmaceuticals Announces Second Quarter 2007 Results
CNNMoney.com - USA
Initiated patient enrollment for TRIMESTA (oral estriol) for multiple sclerosis (MS) in a multi-center Phase II/III clinical trial for the treatment of ...
See all stories on this topic

Tiny Accentia Biopharmaceuticals May Be On Its Way To Big Things
Seeking Alpha - New York,NY,USA
They are aiming at Multiple Sclerosis as their first Phase Three clinical trial. Dr Howard Weiner, who is the Robert L. Kroc Professor of Neurology at ...
See all stories on this topic

BWS Financial Raises Their Price Target on Biogen IDEC (BIIB) to $64
StreetInsider.com (subscription) - Birmingham,MI,USA
The firm said, "We are updating our projected earnings estimates for the remainder of 2007 and 2008 based on the assumption that Tysabri would gain final ...
See all stories on this topic

Hemispherx Biopharma Announces Interim Financial Results for the ...
CNNMoney.com - USA
Hemispherx's flagship products include Alferon N Injection(r) and the experimental therapeutics Ampligen(r) and Oragens(r). Alferon N Injection(r) is ...
See all stories on this topic